Skip to main content

UCB Pharma Expands in Smyrna

Published 9/19/2002

UCB Pharma, a developer and commercializer of allergy/asthma medications and central nervous system disorder treatments, will occupy a new 110,000-sf, $15-million facility in early 2003. UCB Pharma currently employs 450 workers.